Grants and Contracts Details
Description
Glucose homeostasis is essential to maintain proper metabolic function. Defects in the pathways that control glucose homeostasis can lead to the pathogenesis of type II diabetes mellitus, one of the six major risk factors
for cardiovascular disease. The major goal of this proposal is to characterize the signal transduction pathway
triggered by glucose that leads to the activation of insulin gene transcription in pancreatic beta-cells. The
beta-cell specific transcription factor Pdx-1 is known to be the target of the glucose signal. Pdx-1 is a
homeodomain transcription factor that is known to activate gene expression of many beta cell specific genes
involved in maintaining glucose homeostasis such as insulin, GLUT-2, and glucokinase. The principal
hypothesis is that Pdx-1 up-regulates insulin gene transcription in response to increases in extracellular
glucose by a yet unknown signal transduction pathway. Studies on Pdx-1 function and regulation by glucose
may reveal novel target proteins for diabetes therapy, as well as increase the knowledge of how transcription
factors are regulated in response to environmental stimuli. The specific aims of this proposal will address
three different aspects of Pdx-1 function and regulation. The first aim focuses on the characterization of Pdx-1
point mutations found in type II diabetic patients. These mutations will be introduced into the mouse Pdx-1
gene to analyze their effects on DNA binding and transactivation. The second aim concentrates on the
analysis of the mechanisms involved in glucose regulation of Pdx-1. This will be done by following the
changes in the subcellular localization of Pdx-1 in response to high extracellular glucose levels. The third aim
is to analyze the binding kinetics of Pdx-1 in vivo. For this purpose we will use an in vivo chromatin
immunoprecipitation assay to measure the amount of Pdx-1 binding to various promoters under different
conditions. The proposed experiments will contribute to our understanding of Pdx-1 function and development
and will provide novel insights which may lead to the prevention of type II diabetes and its secondary
complications such as cardiovascular disease.
Status | Finished |
---|---|
Effective start/end date | 7/1/02 → 6/30/04 |
Funding
- American Heart Association Ohio Valley Affiliate: $34,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.